Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2-Brain Regulation to Achieve Improved Neuroprotection During Early Development (2- BRAINED)

NCT06659809 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.

NCT NCT06659809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06659809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2-Brain Regulation to Achieve Improved Neuroprotection During Early Development (2- BRAINED)
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
April 24, 2023
Completion date
April 24, 2026
Enrollment
159 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

premature birth